This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human FABP2/I-FABP Quantikine ELISA Kit
catalog :
DFBP20
quantity :
1 Kit
price :
655 USD
citations: 28
Reference
Miuma S, Miyaaki H, Taura N, Kanda Y, Matsuo S, Tajima K, et al. Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis. Sci Rep. 2024;14:25003 pubmed publisher
Tamme K, Acosta S, Biloslavo A, Bj xf6 rck M, Casian D, Damaskos D, et al. Biomarkers In Prediction of Acute Mesenteric Ischaemia: a prospective multicentre study (BIPAMI study): a study protocol. BMC Surg. 2024;24:201 pubmed publisher
Liu Q, Wang Z, Sun S, Nemes J, Brenner L, Hoisington A, et al. Association of Blast Exposure in Military Breaching with Intestinal Permeability Blood Biomarkers Associated with Leaky Gut. Int J Mol Sci. 2024;25: pubmed publisher
Rocafort M, Gootenberg D, Lu xe9 vano J, Paer J, Hayward M, Bramante J, et al. HIV-associated gut microbial alterations are dependent on host and geographic context. Nat Commun. 2024;15:1055 pubmed publisher
Chen Y, Han B, Guan X, Du G, Sheng B, Tang X, et al. Enteric fungi protect against intestinal ischemia-reperfusion injury via inhibiting the SAA1-GSDMD pathway. J Adv Res. 2024;61:223-237 pubmed publisher
Huang Y, Zhang L, Karuna S, Andrew P, Juraska M, Weiner J, et al. Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01. Nat Commun. 2023;14:7813 pubmed publisher
Zhang F, Hu Z, Wang Y, Zhang W, Zhou B, Sun Q, et al. Organoids transplantation attenuates intestinal ischemia/reperfusion injury in mice through L-Malic acid-mediated M2 macrophage polarization. Nat Commun. 2023;14:6779 pubmed publisher
Zhang W, Zhou B, Yang X, Zhao J, Hu J, Ding Y, et al. Exosomal circEZH2_005, an intestinal injury biomarker, alleviates intestinal ischemia/reperfusion injury by mediating Gprc5a signaling. Nat Commun. 2023;14:5437 pubmed publisher
Tyszko M, Lema x144 ska Perek A, x15a miechowicz J, Tomaszewska P, Biecek P, Goździk W, et al. Citrulline, Intestinal Fatty Acid-Binding Protein and the Acute Gastrointestinal Injury Score as Predictors of Gastrointestinal Failure in Patients with Sepsis and Septic Shock. Nutrients. 2023;15: pubmed publisher
Stec A, Maciejewska M, Zaremba M, Paralusz Stec K, Michalska M, Rudnicka L, et al. The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study. J Pers Med. 2023;13: pubmed publisher
Zhang F, Chen X, Wang Y, Hu Z, Zhang W, Zhou B, et al. Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia/reperfusion injury via positive regulation of YAP and Nrf2. J Transl Med. 2023;21:264 pubmed publisher
Choi J, Kim J, Park M, Lee H. Effects of Flavonoid-Rich Orange Juice Intervention on Major Depressive Disorder in Young Adults: A Randomized Controlled Trial. Nutrients. 2022;15: pubmed publisher
Assante G, Tourna A, Carpani R, Ferrari F, Prati D, Peyvandi F, et al. Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death. Sci Rep. 2022;12:18792 pubmed publisher
Deng H, He L, Wang C, Zhang T, Guo H, Zhang H, et al. Altered gut microbiota and its metabolites correlate with plasma cytokines in schizophrenia inpatients with aggression. BMC Psychiatry. 2022;22:629 pubmed publisher
Prasad R, Patton M, Floyd J, Fortmann S, Dupont M, Harbour A, et al. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis. Int J Mol Sci. 2022;23: pubmed publisher
Hasan M, Gazi M, Das S, Fahim S, Hossaini F, Khan A, et al. Gut biomolecules (I-FABP, TFF3 and lipocalin-2) are associated with linear growth and biomarkers of environmental enteric dysfunction (EED) in Bangladeshi children. Sci Rep. 2022;12:13905 pubmed publisher
Gandini A, De Maayer T, Munien C, Bertrand K, Cairns R, MAYNE A, et al. Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa. Cytokine. 2022;157:155945 pubmed publisher
Logan M, Mackinder M, Clark C, Kountouri A, Jere M, Ijaz U, et al. Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease. BMC Gastroenterol. 2022;22:260 pubmed publisher
Wang Y, Dan K, Xue X, Yang X, Feng X, Yang Q, et al. Translocating lipopolysaccharide correlates with the severity of enterovirus A71-induced HFMD by promoting pro-inflammation and viral IRES activity. Gut Pathog. 2021;13:69 pubmed publisher
Feng V, Bawa K, Marzolini S, Kiss A, Oh P, Herrmann N, et al. Impact of 12-week exercise program on biomarkers of gut barrier integrity in patients with coronary artery disease. PLoS ONE. 2021;16:e0260165 pubmed publisher
Schei K, Simpson M, Øien T, Salamati S, Rudi K, Ødegård R. Allergy-related diseases and early gut fungal and bacterial microbiota abundances in children. Clin Transl Allergy. 2021;11:e12041 pubmed publisher
Keane J, Khashan A, McCarthy F, Kenny L, COLLINS J, O Donovan S, et al. Identifying a biological signature of prenatal maternal stress. JCI Insight. 2021;6: pubmed publisher
Wiedemann A, Foucat E, Hocini H, Lefebvre C, Hejblum B, Durand M, et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat Commun. 2020;11:3730 pubmed publisher
Krychtiuk K, Richter B, Lenz M, Hohensinner P, Huber K, Hengstenberg C, et al. Epinephrine treatment but not time to ROSC is associated with intestinal injury in patients with cardiac arrest. Resuscitation. 2020;155:32-38 pubmed publisher
Giron L, Tanes C, Schleimann M, Engen P, Mattei L, Anzurez A, et al. Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020;13:753-766 pubmed publisher
Shieh A, Epeldegui M, Karlamangla A, Greendale G. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight. 2020;5: pubmed publisher
Bartels R, Chimwezi E, Watson V, Pei L, Potani I, Allubha B, et al. Hypoallergenic and anti-inflammatory feeds in children with complicated severe acute malnutrition: an open randomised controlled 3-arm intervention trial in Malawi. Sci Rep. 2019;9:2304 pubmed publisher
Peters E, Dekkers M, van Leeuwen Hilbers F, Daams F, Hulsewé K, de Jonge W, et al. Relation between postoperative ileus and anastomotic leakage after colorectal resection: a post hoc analysis of a prospective randomized controlled trial. Colorectal Dis. 2017;19:667-674 pubmed publisher
product information
master code :
DFBP20
SKU :
DFBP20
product name :
Human FABP2/I-FABP Quantikine ELISA Kit
unit size :
1 Kit
description :
The Human FABP2/I-FABP Quantikine ELISA Kit from R&D Systems quantifies human FABP2/I-FABP in cell culture supernates (50 ul), cell lysates (50 ul), serum (10 ul), edta plasma (10 ul), heparin plasma (10 ul), urine (50 ul).
target :
FABP2/I-FABP
category :
ELISAs
species :
Human
specificity :
Natural and recombinant human FABP2
gene symbol :
FABP2
assay length :
4.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Cell Lysates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Urine (50 uL)
elisaSensitivity :
6.21 pg/mL
elisaRange :
15.60 - 1000 pg/mL
top caption :
Human FABP2/I-FABP ELISA Linearity
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Human FABP2/I-FABP Immunoassay is a 4.5 hour solid phase ELISA designed to measure FABP2 levels in cell culture supernates, cell lysates, serum, plasma, and urine. It contains E. coli -expressed recombinant human FABP2 and antibodies raised against the recombinant protein. Results obtained for naturally occurring human FABP2 showed linear curves that were parallel to the standard curves obtained using the Quantikine Human FABP2 Immunoassay standards. These results indicate that this kit can be used to determine relative mass values for natural human FABP2.
alt names :
FABPI, fatty acid binding protein 2, intestinal, Fatty acid-binding protein 2, fatty acid-binding protein, intestinal, IFABP, I-FABP, I-FABPMGC133132, Intestinal FABP, Intestinal-type fatty acid-binding protein
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.